News Search Results
Feb 28, 2025, 11:30 ET Disposable Gloves Market Size to Reach a Value of US$17.66 Billion by 2031, The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 28, 2025, 11:15 ET Expanded Polystyrene (EPS) Market to be Worth US$ 14.64 Billion by 2031, Driven by Expanding Packaging Industry and Growing Residential and Commercial Construction Activities
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 28, 2025, 11:00 ET Cosmetic Polymer Ingredients Market Size to Become Worth US$ 11.59 billion by 2031 | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 28, 2025, 10:45 ET Lettuce Seeds Market Size to be Worth US$ 372.23 Million by 2031 Owing to Surging Demand for Lettuce and the Growing Popularity of Lettuce Seeds | Exclusive Report by The Insight Partners
China, the US, and India are major markets of lettuce seeds. Innovations in seed technology, such as biotechnology and precision agriculture, are enhancing crop resilience and productivity, further stimulating the market growth. Additionally, the trend toward
More news about: The Insight Partners
Feb 28, 2025, 10:30 ET pH Buffer Solution Market Size to Become a Worth US$ 2.26 Billion by 2031 Driven by Increased Applications in Laboratories | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Feb 28, 2025, 10:18 ET Apertura Gene Therapy Supports the Broad Institute in Development of Gene Therapy for Prion Disease Using Engineered AAV Capsid Targeting TfR1 for CNS Delivery
NEW YORK, Feb. 28, 2025 /PRNewswire/ -- Apertura Gene Therapy, a biotechnology company focused on innovative gene therapy solutions, supports the Broad Institute of MIT and Harvard,
More news about: Apertura Gene Therapy
Feb 28, 2025, 10:00 ET Lilly to participate in Leerink Partners Global Healthcare Conference
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Feb 28, 2025, 10:00 ET NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES DETAILS OF LACRIFILL® CANALICULAR GEL POSTER PRESENTATION AT SECO 2025
Group B.V., is partnered with well-established global biopharmaceutical companies and is uniquely positioned to leverage its expertise in bringing biotechnology derived medicines, sterile manufacturing and other state-of-the-art technologies to the marketplace. Safe Harbor This press
More news about: Nordic Pharma
Feb 28, 2025, 10:00 ET NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES DETAILS OF LACRIFILL® CANALICULAR GEL POSTER PRESENTATION AT SECO 2025
Group B.V., is partnered with well-established global biopharmaceutical companies and is uniquely positioned to leverage its expertise in bringing biotechnology derived medicines, sterile manufacturing and other state-of-the-art technologies to the marketplace. Safe Harbor This press
More news about: Nordic Pharma
Feb 28, 2025, 09:58 ET Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT001, a Novel Multi-Targeting, Half-Life Extended Bispecific Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Skin Diseases
Feb. 28, 2025 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Bambusa), a clinical-stage biotechnology company developing novel biologics for inflammatory and immunological diseases, today announced the initiation of dosing in healthy volunteers (HV)
More news about: Bambusa Therapeutics
Feb 28, 2025, 09:00 ET Visionary Holdings: Generative AI Leads the Efficiency Revolution, Reshaping the Future of FinTech and Biotechnology
Visionary Holdings has emerged as a leader in this technological transformation, achieving groundbreaking progress in FinTech, digital currencies, and biotechnology through deep research and development in generative AI. In the FinTech and digital currency sectors, traditional operational models face
More news about: Visionary Holdings Inc.
Feb 28, 2025, 09:00 ET Q32 Bio Announces Late-Breaking Presentation of Results from SIGNAL-AA Part A Clinical Trial of Bempikibart in Alopecia Areata at the 2025 American Academy of Dermatology Annual Meeting
Feb. 28, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced that results from Part A of its SIGNAL-AA Phase
More news about: Q32 Bio
Feb 28, 2025, 08:23 ET The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease
LinkedIn. 5. About BiogenFounded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient's lives and to create value for shareholders and our communities.
More news about: Eisai Inc.
Feb 28, 2025, 08:14 ET Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) previously treated with a BTK inhibitor
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Feb 28, 2025, 07:00 ET GenBio AI Expands Global Leadership with Ziv Bar-Joseph as Co-Founder and Chief Scientific Officer
to have him on board as we push the frontiers of scientific discovery." GenBio AI is laying the foundation for a new era in medicine and biotechnology. Its system of integrated multiscale foundation models is used to obtain global view of the underlying biology of living cells, tissues and organs.
More news about: GenBio AI
Feb 28, 2025, 07:00 ET GenBio AI Expands Global Leadership with Ziv Bar-Joseph as Co-Founder and Chief Scientific Officer
to have him on board as we push the frontiers of scientific discovery." GenBio AI is laying the foundation for a new era in medicine and biotechnology. Its system of integrated multiscale foundation models is used to obtain global view of the underlying biology of living cells, tissues and organs.
More news about: GenBio AI
Feb 28, 2025, 07:00 ET SKYLINEDX ANNOUNCES NEW PUBLICATION ON SKY92 GENE EXPRESSION PROFILING TEST in DEFINING ULTRA-HIGH-RISK MULTIPLE MYELOMA
CAP/CLIA lab in San Diego (CA, USA). About SkylineDx SkylineDx is a biotechnology company focused on research & development of molecular diagnostics in oncology inflammatory, and infectious diseases. SkylineDx uses its expertise
More news about: SkylineDx
Feb 28, 2025, 06:30 ET Magnet Biomedicine Enters into a Collaboration and License Agreement with Lilly to Discover and Develop Novel Molecular Glue Medicines
disease-relevant tissues and addressing historically difficult-to-drug proteins. About Magnet BiomedicineMagnet Biomedicine is a biotechnology company advancing molecular glue discovery with rational selection and design. Magnet is harnessing the vast untapped potential of TrueGlues to
More news about: Magnet Biomedicine
Feb 28, 2025, 05:45 ET ICON Public Limited Company Class Action: Levi & Korsinsky Reminds ICON Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 11, 2025 - ICLR
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Levi & Korsinsky, LLP
Feb 28, 2025, 05:00 ET A*STAR And MojiaBio To Develop Next-gen Sustainable Biomanufacturing Platform In Singapore
primarily located in Biopolis and Fusionopolis. About A*STAR Singapore Institute of Food and Biotechnology Innovation (A*STAR SIFBI) A*STAR Singapore Institute of Food and Biotechnology Innovation (A*STAR SIFBI)'s vision is to be an innovation engine for health and well-being, focusing
More news about: MojiaBio
Feb 28, 2025, 03:37 ET Amity University Rajasthan Celebrates Class of 2024 at Prestigious Convocation Ceremony
2025. Amity University Rajasthan, Jaipur provides students with cutting-edge laboratories for languages, media studies, education, pharmacy, biotechnology, engineering, hotel management, business management, and scientific research, as well as sophisticated facilities for a variety of research projects.
More news about: Amity University Rajasthan
Feb 27, 2025, 17:31 ET Global High Potency Active Pharmaceutical Ingredients Market to Surpass USD 45 Billion Mark by 2032 | DelveInsight
the United States. For example, in June 2022, Pfizer Inc., a U.S.-based pharmaceutical and biotechnology company, announced a $120 million investment in its Kalamazoo, Michigan facility
More news about: DelveInsight Business Research, LLP
Feb 27, 2025, 16:05 ET Spyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Feb. 27, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ:SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations to target improved efficacy and convenience
More news about: Spyre Therapeutics, Inc.
Feb 27, 2025, 12:58 ET Guidelines for Designing Consent Materials and Procedures For Autistic Adults and People with Intellectual Disability
company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, and public health and policy. For complete information, please visit the
More news about: Mary Ann Liebert, Inc.
Feb 27, 2025, 12:00 ET ICON plc (ICLR) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
offerings were insufficient to shield the Company from the adverse effects of a significant market downturn; (3) that the RFPs ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: Glancy Prongay & Murray LLP